Jump to content
Crime Forum
FORUMS BLOG/NEWS USER BLOGS USER MEDIA ADVERTS   ADD  MANAGE CHAT CLUBS & USER'S PERSONAL FORUMS LINK EXCHANGE
  • entries
    405
  • comments
    0
  • views
    1,167

About this blog

Drug repurposing enables drug developers to optimize on past efforts and expenditure, thereby, offering a viable life cycle management strategy for marketed products and opportunities to re-evaluate failed / shelved drug development programs

 

Roots Analysis is pleased to announce the publication of its recent study, titled, “Drug Repurposing Service Providers Market, 2020-2030.

 

The report features an extensive study of the current market landscape and future opportunities for players offering services for repurposing / repositioning / reprofiling of drug candidates. It features an in-depth analysis, highlighting the capabilities of various service providers engaged in this domain. In addition to other elements, the study includes:

§  A detailed assessment of the current market landscape of companies offering drug repurposing services. 

§  Elaborate profiles of key players that specialize in offering services for the development of repurposed drugs.

§  An analysis of the partnerships that have been established in this domain, in the recent past.

§  An analysis of the initiatives of big biopharma players engaged in this domain.

§  A detailed analysis of more than 1,700 terminated / withdrawn / suspended clinical studies of the drug candidates.

§  A detailed analysis on the cost saving potential of drug repurposing approaches, as compared to the traditional de novo drug development methods.

§  A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)

  • Type of Repurposing Approaches

§  Disease-centric approach

§  Target-centric approach

§  Drug-centric approach

  • Therapeutic Area

§  Same Therapeutic Area

§  Different Therapeutic Area

  • Type of Drug Molecule

§  Biologics 

§  Small Molecule

  • Key Geographical Region 

§  North America

§  Europe

§  Asia-Pacific

 

Key companies covered in the report

§  Auxillis Pharma

§  ChemBio Discovery Solutions

§  Excelra

§  GVK Bio

§  Iris Pharma

§  Lantern Pharma

§  PanXome

§  Pharmacelera

§  Physiogenex

§  Smart Pharma

§  Socium

§  SOM Biotech

 

For more information please click on the following link:

https://www.rootsanalysis.com/reports/drug-repurposing-service-provides.html

 

Other Recent Offerings

1.     Peptides and Macrocycle Drug Discovery: Services and Platforms Market, 2020 - 2030

2.     China Biopharmaceutical Contract Manufacturing Market, 2020-2030

3.     Antibody Contract Manufacturing Market, 2020 - 2030

 

About Roots Analysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

 

Contact Information

Roots Analysis Private Limited

Gaurav Chaudhary

+1 (415) 800 3415

gaurav.chaudhary@rootsanalysis.com

 

 

Entries in this blog

The antibody contract manufacturing market is projected to grow at an annualized rate of 12%{RootsAnalysis}

Roots Analysis has done a detailed study on Antibody Contract Manufacturing Market, 2020-2030, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.   To order this 285+ page report, which features 100+ figures and 110+ tables, please visit this -https://www.rootsanalysis.com/reports/view_document/antibody-cmo-market/295.html   Key Market Insights §  Several companies worldwide claim to possess the required expertise an

The antibody contract manufacturing market is estimated to be worth USD 17 billion in 2030(RootsAnalysis)

Roots Analysis is pleased to announce the publication of its recent study, titled, “Antibody Contract Manufacturing Market, 2020-2030” report to its list of offerings.   The report features an extensive study of the current market landscape and future opportunities associated with the contract manufacturing of antibodies. The study also features a detailed analysis of key drivers and trends related to this evolving domain. In addition to other elements, the study includes: §  A d

Narender

Narender in Roots Analysis

The antibody contract manufacturing market is projected to reach USD 17 billion by 2030(Roots)

Roots Analysis has announced the addition of the “Antibody Contract Manufacturing Market, 2020-2030” report to its list of offerings.   Although biopharmaceuticals offer significant profit margins and have been proven to be effective in treating a myriad of diseases, they are generally associated with high costs of development and complex manufacturing protocols; this is true for antibody-based products as well. Presently, there are a number of companies that claim to offer end-to-end

Narender

Narender in Roots Analysis

The “Bispecific Antibody Therapeutics Market (4th Edition), 2019-2030<RootsAnalysis>

https://www.rootsanalysis.com/reports/view_document/bispecific-antibodies/286.html   Key Inclusions §  A detailed review of the overall landscape of bispecific antibody therapeutics, including information on drug developers, phase of development (marketed, clinical, and preclinical / discovery) of the pipeline candidates, target antigen, type of antibody format, mechanism of action, target disease indication(s), therapeutic area, broader disease segment, route of administration, m

Narender

Narender in Roots Analysis

With two approved drugs and close to 300 clinical / preclinical product candidates<Roots>

With various target combinations and novel mechanisms of action, bispecific antibodies are presently recognized as a potent class of targeted therapies, with the potential to be used as treatment options for a variety of disease indications. Several pipeline candidates have recently entered mid to late-stage (phase II and above) trials and are anticipated to enter the market over the next 5-10 years.   To order this 370+ page report, which features 90+ figures and 110+ tables, please v

Narender

Narender in Roots Analysis

The bispecific antibody therapeutics market is projected to grow at an annualized rate of ~16%: By RootsAnalysis:

Roots Analysis has done a detailed study on Bispecific Antibody Therapeutics Market (4th Edition), 2020-2030, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.   To order this 370+ page report, which features 90+ figures and 110+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/bispecific-antibodies/286.html   Key Market Insights          §  With two approved drugs and close to 300 clin

Narender

Narender in Roots Analysis

The bispecific antibody therapeutics market is estimated to be worth USD 6.9 billion in 2030:By Roots:

Roots Analysis is pleased to announce the publication of its recent study, titled, “Bispecific Antibody Therapeutics Market (4th Edition), 2020-2030.”   The report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of these therapeutics over the next decade. The study features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. Amongst other elements, the report includes:

The “Global Handheld Ultrasound Imaging Devices Market, 2020-2030: RootsAnalysis:

https://www.rootsanalysis.com/reports/view_document/handheld-imaging-devices/319.html   Key Inclusions §  An overview of the current market landscape of the handheld ultrasound imaging devices, providing information on the status of development, application area (abdomen, cardiac, gynecological, pulmonary, urological scanning and others), weight of device, type of transducer array (convex / curved, linear, micro-convex, transvaginal, phased and others), transducer frequency, mode

Narender

Narender in Roots Analysis

Several players are currently engaged in the development / manufacturing over 100 point-of-care{RootsAnalysis}

According to industry experts, handheld ultrasound imaging devices are being adopted at a faster pace by different end-users owing to their higher efficiency and wider applicability. Further, these devices have proven to be useful in quarantining patients demonstrating symptoms of pleural wall thickening and lung congestion, a characteristic of pneumonia, as well as observed in patients suffering from the novel coronavirus (COVID-19).   To order this 235+ page report, which features 9

Narender

Narender in Roots Analysis

The global handheld ultrasound imaging devices market is projected to be over USD 1.1 billion by 2030{Roots}

Roots Analysis has done a detailed study on “Global Handheld Ultrasound Imaging Devices Market, 2020-2030” covering key aspects of the industry’s evolution and identifying potential future growth opportunities.   To order this 235+ page report, which features 95+ figures and 110+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/handheld-imaging-devices/319.html   Key Market Insights §  Several players are currently engaged in the developme

Narender

Narender in Roots Analysis

The global handheld ultrasound imaging devices market is projected(RootsAnalysis)

Advances in the field of disease diagnostics have led to a substantial increase in the development of point-of-care medical imaging devices; handheld ultrasound scanners have emerged as a novel solution to cater to the unmet need in this domain. In fact, the demand for handheld ultrasound devices is on a surge amidst the COVID-19 pandemic. These portable, pocket-friendly, point-of-care devices have revolutionized the treatment of COVID-19 patients by provide remote access to doctors and ensures

Narender

Narender in Roots Analysis

The global handheld ultrasound imaging devices market(Roots)

Roots Analysis has announced the addition of “Global Handheld Ultrasound Imaging Devices Market, 2020-2030” report to its list of offerings.   According to industry experts, handheld ultrasound imaging devices are being adopted at a faster pace by different end-users owing to their higher efficiency and wider applicability. Further, these devices have proven to be useful in quarantining patients demonstrating symptoms of pleural wall thickening and lung congestion, a characteristic of

Narender

Narender in Roots Analysis

The “Biopharmaceutical Contract Manufacturing Market (3rd edition), 2019 – 2030<RootsAnalysis>

https://rootsanalysis.com/reports/view_document/biopharma-contract-manufacturing-market-3rd-edition-2019-2030/250.html   Key Inclusions §  A detailed review of the overall landscape of the biopharmaceutical contract manufacturing market, featuring a comprehensive list of active CMOs and detailed analysis of the manufacturing service providers based on a number of parameters, such as scale of operation (preclinical, clinical and commercial), type of biologics manufactured (peptides

Narender

Narender in Roots Analysis

Over 235 companies worldwide claim to offer contract manufacturing services<Roots>

Owing to the ever-increasing number of start-ups that are involved in R&D of novel biologics, there is an enormous opportunity for the CMOs in this domain. It is worth emphasizing that, since 2000, more than 115 new CMOs have been established in order to serve to the growing demand for novel biologics that have specific manufacturing requirements. The contemporary contract services market features a mix of large and small-sized CMOs and is characterized by multiple mergers and acquisitions a

Narender

Narender in Roots Analysis

The biopharmaceutical contract manufacturing market is projected to grow: By RootsAnalysis:

Roots Analysis has done a detailed study on Biopharma Contract Manufacturing Market (3rd Edition), 2019-2030, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.   To order this 750+ page report, which features 200+ figures and 250+ tables, please visit this - https://rootsanalysis.com/reports/view_document/biopharma-contract-manufacturing-market-3rd-edition-2019-2030/250.html   Key Market Insights §  Over 235 companie

Narender

Narender in Roots Analysis

The biopharmaceutical contract manufacturing market is estimated to be worth USD 13.9 billion in 2030: By Roots:

Roots Analysis is pleased to announce the publication of its recent study, titled,  “Biopharma Contract Manufacturing Market (3rd Edition), 2019-2030.”    The report features an extensive study on the contract service providers within the biopharmaceutical industry. The study features in-depth analysis, highlighting the capabilities of a diverse set of biopharmaceutical CMOs and CDMOs. Amongst other elements, the report includes: §  A detailed review of the overall landscape of t

Narender

Narender in Roots Analysis

The “Virtual Clinical Trial Service Providers Market, 2020-2050:RootsAnalysis:

https://www.rootsanalysis.com/reports/virtual-clinical-trial-service-provides-market.html   Key Inclusions §  An overview of the current market landscape of companies offering solutions for virtual clinical trials, featuring information on year of establishment, geographical location, company size and types of services offered (study start-up, patient enrollment, drug logistics, data collection and analysis, and patient retention). §  Brief profiles of companies offering solu

Narender

Narender in Roots Analysis

Currently, many companies claim to have advanced technology platforms{RootsAnalysis}

Owing to its patient-centric approach, virtual / decentralized clinical trials are believed to potentially transform the conventional clinical research process. Virtual clinical trials implement innovative and advanced technological solutions, such as telemedicine and remote monitoring to minimize delays associated with the overall drug development process. The increased adoption of digital solutions by the healthcare industry and the cost saving potential of virtual clinical trials are likely t

Narender

Narender in Roots Analysis

The virtual clinical trial service providers market is projected to grow at an annualized rate{Roots}

Roots Analysis has done a detailed study on Virtual Clinical Trial Service Providers Market, 2020-2050, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.   To order this 280+ page report, which features 180+ figures and 230+ tables, please visit this link   Key Market Insights §  Currently, many companies claim to have advanced technology platforms, which enable them to decentralize the clinical research process, the

Narender

Narender in Roots Analysis

The virtual clinical trial service providers market is estimated to be worth USD 12 billion in 2050(RootsAnalysis)

Conventional clinical trials are fraught with inefficient patient management and data handling practices, which has prompted trial sponsors to implement digital innovation and virtual technologies across different aspects of drug development.   Roots Analysis is pleased to announce the publication of its recent study, titled, “Virtual Clinical Trial Service Providers Market, 2020-2050”   The report features an extensive study of the current landscape of industry players that

Narender

Narender in Roots Analysis

The “Gene Therapy Market (4th Edition), 2020-2030(Roots)

https://www.rootsanalysis.com/reports/view_document/gene-therapies-market/268.html   Key Inclusions §  A detailed review of the overall market landscape of gene therapies and gene editing therapies, including information on phase of development (marketed, clinical, preclinical and discovery) of pipeline candidates, key therapeutic areas (autoimmune disorders, cardiovascular diseases, dermatological disorders, genetic disorders, hematological disorders, immunological disorders, inf

Narender

Narender in Roots Analysis

The gene therapy market is characterized by a healthy drug pipeline, with 10 approved<RootsAnalysis>

Success of approved gene therapies has resulted in a surge in interest of biopharmaceutical developers in this rapidly evolving domain. Presently, the ability of gene therapies to treat diverse disease indications is considered among the most prominent drivers of this market. In addition, promising clinical results of pipeline candidates are anticipated to draw in more investments to support product development initiatives.   To order this 720+ page report, which features 220+ figures

Narender

Narender in Roots Analysis

The gene therapy market is projected to grow at an annualized rate of 30%, till 2030<Roots>

Roots Analysis has done a detailed study on Gene Therapy Market (4th Edition), 2020-2030, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.   To order this 720+ page report, which features 220+ figures and 375+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/gene-therapies-market/268.html   Key Market Insights §  The gene therapy market is characterized by a healthy drug pipeline, with

Narender

Narender in Roots Analysis

The gene therapy market is estimated to be worth USD 14.6 billion in 2030: By RootsAnalysis:

Roots Analysis is pleased to announce the publication of its recent study, titled, “Gene Therapy Market (4th Edition), 2020-2030”.   The report features an extensive study of the current market landscape of gene therapies, primarily focusing on gene augmentation-based therapies, oncolytic viral therapies, immunotherapies and gene editing therapies. The study also features an elaborate discussion on the future potential of this evolving market. In addition to other elements, the study i

Narender

Narender in Roots Analysis

The gene therapy market is projected to be worth USD 14.6 billion in 2030:By Roots:

Roots Analysis has announced the addition of “Gene Therapy Market (4th Edition), 2020-2030” report to its list of offerings.   Success of approved gene therapies has resulted in a surge in interest of biopharmaceutical developers in this rapidly evolving domain. Presently, the ability of gene therapies to treat diverse disease indications is considered among the most prominent drivers of this market. In addition, promising clinical results of pipeline candidates are anticipated to draw

Narender

Narender in Roots Analysis

×
  • Create New...